Skip to main content
. 2012 Dec 8;12:74. doi: 10.1186/1471-2466-12-74

Figure 1.

Figure 1

Trough FEV1dose−response results at 24 hours at steady-state (modified intent-to-treat population). Model average placebo-adjusted values for OD and BID dosing regimens, with 90% confidence limits (red and blue shaded areas, respectively). FEV1: forced expiratory volume in one second; OD: once daily; BID: twice daily.